Search

Ipsen SA.

Fechado

SetorFinanças

145 2.18

Visão Geral

Variação de preço das ações

24h

Atual

Mín

140.3

Máximo

145.19

Indicadores-chave

By Trading Economics

Rendimento

294M

403M

Vendas

334M

2.2B

P/E

Médio do Setor

23.317

19.443

Rendimento de Dividendos

1.12

Margem de lucro

18.405

Funcionários

5,535

EBITDA

556M

1B

Recomendações

By TipRanks

Recomendações

Neutro

Previsão para 12 meses

+19.21% upside

Dividendos

By Acuity

Rendimento de Dividendos

Médio do Setor

1.12%

4.82%

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

-1.2B

12B

Abertura anterior

142.82

Fecho anterior

145

Ipsen SA. Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

13 de out. de 2026, 23:51 UTC

News

Etsy Inc shares are trading lower in after-market hours despite Payoneer's renewal of its partnership through 2029 to support international sellers.

13 de out. de 2026, 23:51 UTC

News

DraftKings Inc shares are trading lower in after-market hours as the FTC launches a preliminary inquiry into potential deceptive practices in the sports betting industry.

13 de out. de 2026, 23:51 UTC

News

UBS maintains a Buy rating on Apollo Global Management while lowering its price target to $163, citing a 17.36% average annual return over 15 years.

13 de out. de 2026, 23:41 UTC

News

Citigroup maintains a Neutral rating on Phillips 66 and raises its price target to $297, reflecting ongoing confidence in the company's performance.

13 de out. de 2026, 23:41 UTC

News

Shares of Wayfair Inc are trading lower in after-market hours following the announcement of an expanded partnership with Klarna Group, offering 0% APR financing.

13 de out. de 2026, 23:41 UTC

News

Cheniere Energy Inc shares declined modestly in after-market trading amid rising LNG prices in Asia and concerns over low gas storage levels in Europe.

13 de out. de 2026, 23:36 UTC

News

L3Harris Technologies partners with Divergent Technologies to enhance production capabilities for its Wolf Pack munitions, utilizing additive manufacturing for battlefield adaptability.

13 de out. de 2026, 23:36 UTC

News

PG&E Corp prepares for potential Public Safety Power Shutoffs affecting 70k customers across 29 counties due to high winds and dry conditions.

13 de out. de 2026, 23:31 UTC

News

B&G Foods Inc sells its B&M and Joan of Arc brands to McCall Farms, aiming to use proceeds for long-term debt repayment.

13 de out. de 2026, 23:26 UTC

News
Correlated Moves

ServiceNow is reportedly in early discussions to acquire AI startup Decagon, which was valued at $4.5 billion earlier this year.

13 de out. de 2026, 23:26 UTC

News

Leidos Holdings awarded a $317.99 million contract by the Defense Health Agency for MHS Genesis system reintegration and software services, running from 2026 to 2028.

13 de out. de 2026, 23:16 UTC

News

Citigroup maintains Buy rating on Tractor Supply Co and raises price target to $38, providing a bullish outlook for the company.

13 de out. de 2026, 23:16 UTC

News
Correlated Moves

Welltower to sell 30 leased communities to Brookdale Senior Living for $290 million, reducing Brookdale's annual cash rent payments by about $17.8 million.

13 de out. de 2026, 23:16 UTC

News

A securities class action lawsuit has been filed against DICK'S Sporting Goods, alleging misleading statements about financial performance and inventory management.

13 de out. de 2026, 23:11 UTC

News
Social Media

Microsoft directs senior leaders to cut Azure costs by 20%, amid ongoing restructuring, according to a report from The Information.

13 de out. de 2026, 23:11 UTC

News
Correlated Moves

The USD/SEK is modestly lower following the NFIB Small Business Optimism Index for September, which came in at 97.9, below the forecast of 98.1.

13 de out. de 2026, 23:06 UTC

News

Cirrus Logic withdraws its acquisition proposals for Synaptics, confirming its role as "Party A" in the pending merger with ON Semiconductor.

13 de out. de 2026, 23:06 UTC

News

Interactive Brokers Group Inc shares are declining in after-market trading, despite a 35% year-over-year increase in client accounts and the launch of Ethereum staking services.

13 de out. de 2026, 23:06 UTC

News

NetApp Inc shares declined during after-market hours on Tuesday, though they remained above their lowest point reached after the regular session ended.

13 de out. de 2026, 23:06 UTC

Correlated Moves
News

Wells Fargo shares are little changed in after-market trading, having retraced from earlier gains despite Citigroup's higher performance following its earnings results.

13 de out. de 2026, 23:06 UTC

News

UBS reaffirms Buy rating on KKR & Co Inc, lowering price target to $122; KKR Fs Income Trust secures up to $250M loan agreement.

13 de out. de 2026, 23:02 UTC

Macro News
News

Bitcoin advances as a UK High Court ruling permits retention of 61k seized BTC, while Russia's Sberbank is authorized to facilitate Bitcoin transactions.

13 de out. de 2026, 23:01 UTC

News

Cisco Systems Inc shares declined in after-market trading, with a put/call ratio of 0.66 indicating a moderately bearish outlook among traders.

13 de out. de 2026, 23:01 UTC

News

Rivian Automotive appoints Doug Field as president of Mind Robotics, focusing on AI and robotics in manufacturing, with the spinoff securing over $1 billion for development.

13 de out. de 2026, 23:01 UTC

News

Quarterly cash dividend raised to $0.26; 650k shares repurchased.

13 de out. de 2026, 23:01 UTC

News

USD/ZAR is trading modestly lower, influenced by the U.S. NFIB Small Business Optimism index, which came in at 97.9, below the forecast of 98.1.

13 de out. de 2026, 23:01 UTC

News
Correlated Moves

USD/NOK is modestly lower following the release of U.S. NFIB small business optimism data for September, which came in at 97.9, below expectations.

13 de out. de 2026, 23:01 UTC

News

Energy Fuels Inc filed a prospectus to offer common shares of up to $500 million to raise capital.

13 de out. de 2026, 23:01 UTC

News
Social Media

GameStop shares advanced after CEO Ryan Cohen disclosed the purchase of 844.13k shares, increasing his stake to approximately 9.1%, totaling over $22 million.

13 de out. de 2026, 23:01 UTC

Event
Social Media
News

AZZ Inc. reported fiscal Q2 sales of $486.9 million and adjusted EPS of $2.00, raising its fiscal year 2027 guidance for EPS and sales.

Comparação entre Pares

Variação de preço

Ipsen SA. Previsão

Preço-alvo

By TipRanks

19.21% parte superior

Previsão para 12 meses

Média 170 EUR  19.21%

Máximo 235 EUR

Mínimo 130 EUR

Com base em 4 analistas de Wall Street que oferecem metas de preço de 12 meses para Ipsen SA. - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Neutro

4 ratings

1

Comprar

1

Manter

2

Vender

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Ipsen SA.

Ipsen S.A. operates as a biopharmaceutical company worldwide. The company provides drugs in the areas of oncology, neuroscience, and rare diseases. Its product pipeline comprises Cabometyx + Atezolizumab, which is in phase III clinical trial for the treatment of second line metastatic castration-resistant prostate cancer; lenalidomide and rituximab, and Taverik, which is in phase III for the treatment of second line follicular lymphoma; Bylvay, which is in phase III for the treatment of biliary atresia; Dysport, which is in phase III clinical trial for the treatment of chronic and episodic migraine; Fidrisertib, which is in phase II clinical trial for the treatment of fibrodysplasia ossificans progressiva; Elafibranor, which is in phase II for the treatment of primary sclerosing cholangitis, as well as IPN60250; IPN10200, which is in phase II for the treatment of longer-acting neurotoxin aesthetics and therapeutics; IPN60210, which is in phase I clinical trial for the treatment of relapsed/refractory multiple myeloma; and IPN60260 for the treatment of Viral cholestatic disease and is in phase I clinical trial. The company also offers Somatuline, Decapeptyl, Cabometyx, Onivyde, Tazverik, and other oncology products; Dysport and other neurosciences products; and Bylvay, NutropinAq, Increlex, and Sohonos for rare diseases. The company was founded in 1929 and is based in Boulogne-Billancourt, France.
help-icon Live chat